Cardiac Catheterization in the ASC: Strategic Considerations for Hospitals and 卫生系统


As the US healthcare system continues to grapple with the implications of the COVID-19 pandemic, and as states begin reopening facilities for elective procedures, healthcare providers are facing limitations on providing timely elective cardiovascular (CV) care—limitations that, 再加上接触COVID-19的风险, can potentially impact morbidity and mortality.

急诊和选择性手术, the need for a COVID-19-free environment has escalated the demand for alternative sites of service by patients and providers.

To aid in striking the delicate balance between safe and timely care, 美国心脏协会, 还有北美的14个CV社团, has offered guidance on a phased approach to safely reintroduce diagnostic and interventional CV procedures during the pandemic.1 Part of this strategy involves shifting lower-acuity and routine diagnostic procedures out of the hospital to expand inpatient capacity for sicker patients.

尽管很紧迫, COVID-19 is only the most recent factor accelerating the migration of surgical procedures to outpatient (OP) settings—and it only heightens the need for hospitals to understand the complexity of merging CV services with an ambulatory surgery strategy.


在过去的两年里, CMS has implemented ambulatory surgery center (ASC) rule changes that have the potential to dramatically alter the way hospitals and health systems run their CV service lines. 因为这些规则的改变, 14 new primary cardiac catheterization and coronary intervention procedures were added to the ASC Medicare-approved list.



This article was first published by Becker’s Hospital Review on July 20, 2020